{
  "id": "64178ec2690f196b51000024",
  "type": "summary",
  "question": "What is viltolarsen's mechanism of action?",
  "ideal_answer": "Viltolarsen is an antisense oligonucleotide designed to bind to and inhibit the production of the mutated dystrophin protein caused by a mutation in the DMD gene. It is designed to increase the production of functional dystrophin protein, which is essential for muscle function.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34938127",
    "http://www.ncbi.nlm.nih.gov/pubmed/32519222",
    "http://www.ncbi.nlm.nih.gov/pubmed/33285037",
    "http://www.ncbi.nlm.nih.gov/pubmed/32955503",
    "http://www.ncbi.nlm.nih.gov/pubmed/36401022",
    "http://www.ncbi.nlm.nih.gov/pubmed/31720560"
  ],
  "snippets": [
    {
      "text": "Viltolarsen is a phosphorodiamidate morpholino antisense oligonucleotide (PMO) designed to skip exon 53 of the DMD gene",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36401022",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Viltolarsen restores the reading frame of the DMD gene by skipping \u00a0exon 53\u00a0and produces a truncated but functional form of dystrophin.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/36401022",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Viltolarsen, also known as NS-065/NCNP-01, is a PMO developed through comprehensive sequence optimization and is designed to skip exon 53 on the DMD primary transcript.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31720560",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Viltolarsen binds to exon 53 of the dystrophin mRNA precursor and restores the amino acid open-reading frame by skipping exon 53, resulting in the production of a shortened dystrophin protein that contains essential functional portions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32519222",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Viltolarsen is a drug of phosphorodiamidate morpholino oligomer (PMO) chemistry, designed to skip exon 53 of the DMD gene.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34938127",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: The novel morpholino antisense oligonucleotide viltolarsen targets exon 53 of the dystrophin gene, and could be an effective treatment for patients with Duchenne muscular dystr",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33285037",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The morpholino AON viltolarsen (code name: NS-065/NCNP-01) has been shown to induce exon 53 skipping, restoring the reading frame for patients with exon 52 deletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32955503",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}